Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SGMT
Stock Latest News
The Fly
Sagimet Biosciences initiated with a Buy at Rodman & Renshaw
18d ago
SGMT
Premium
Ratings
Sagimet: Advancing FASN Inhibitor Pipeline and Solid Cash Position Support Buy Rating and $26 Target
1M ago
SGMT
Premium
Ratings
Sagimet: Underappreciated, De-Risked Pipeline with Near-Term Milestones Supports Buy Rating
1M ago
SGMT
Premium
Ratings
Sagimet: Undervalued MASH and Acne Pipeline with Best-in-Class Combination Potential Supports Buy Rating
1M ago
SGMT
Premium
Company Announcements
Sagimet Biosciences Reports 2025 Results, Highlights Clinical Progress
1M ago
8K
SGMT
Premium
The Fly
Sagimet Biosciences reports Q4 EPS (29c), consensus (43c)
1M ago
SGMT
Premium
The Fly
Adobe downgraded, Palantir upgraded: Wall Street’s top analyst calls
2M ago
V
MA
Premium
The Fly
Sagimet Biosciences initiated with a Buy at Guggenheim
2M ago
SGMT
Premium
The Fly
Sagimet Biosciences price target raised to $37 from $29 at Clear Street
2M ago
SGMT
Premium
Ratings
Sagimet Therapeutics: Strengthened FASN-Inhibition Safety Profile and Advancing Phase 2 Programs Support Buy Rating
2M ago
SGMT
Premium
Company Announcements
Sagimet Biosciences Reports Positive Phase 3 Acne Data
2M ago
8K
SGMT
Premium
The Fly
Sagimet Biosciences announces license partner Ascletis issues results for ASC40
2M ago
SGMT
Premium
Ratings
Multiple Shots on Goal: Sagimet’s Differentiated MASH Combo and Acne Franchise Underpin Buy Rating and Favorable Risk‑Reward
2M ago
SGMT
Premium
The Fly
Sagimet Biosciences initiated with an Equal Weight at Barclays
3M ago
SGMT
Premium
Ratings
Sagimet Biosciences: Advancing FASN Inhibitor Pipeline and Multi-Indication Opportunities Support Buy Rating and $26 Target
3M ago
SGMT
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks to Buy Now, According to Top Analysts
4M ago
PYXS
RGNX
Premium
Company Announcements
Sagimet Highlights Positive MASH Combo Data and Pipeline Progress
4M ago
8K
SGMT
Premium
The Fly
Sagimet announces results from Phase 1 PK trial of denifanstat, resmetirom
4M ago
SGMT
Premium
Ratings
Strategic Licensing and Pipeline Advancements Drive Buy Rating for Sagimet Biosciences
4M ago
SGMT
Premium
Company Announcements
Sagimet Biosciences enters global license agreement with TAPI
4M ago
8K
SGMT
Premium
The Fly
Sagimet Biosciences announces China’s NMPA accepted NDA for denifanstat
4M ago
SGMT
Premium
Ratings
Buy Rating for Sagimet Biosciences: Promising Pipeline Developments and Strong Financial Position
5M ago
SGMT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
